[Protozoan infections of the skin].
D000666:Amphotericin B / Q000627:therapeutic use; D000965:Antimony / Q000627:therapeutic use; D005260:Female; D005860:Germany, West; D006801:Humans; D007891:Leishmania / Q000302:isolation & purification; D007897:Leishmaniasis, Mucocutaneous / Q000188:drug therapy / Q000453:epidemiology; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D011528:Protozoan Infections / Q000382:microbiology*; D011739:Pyrimethamine / Q000627:therapeutic use; D012874:Skin Diseases, Infectious / Q000382:microbiology*; D013307:Streptomycin / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000175:diagnosis / Q000188:drug therapy; D014244:Trichomonas / Q000302:isolation & purification; D014245:Trichomonas Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D014247:Trichomonas Vaginitis / Q000175:diagnosis / Q000188:drug therapy; D014246:Trichomonas vaginalis
D008795:Metronidazole; D000666:Amphotericin B; D000965:Antimony; D013307:Streptomycin; D011739:Pyrimethamine
Protozoeninfektionen der Haut